On Saturday, Brazil began distributing about 2 million doses of the AstraZeneca coronavirus vaccine, Brazilian health officials announced.
Seconds Reuters, The Fiocruz Institute, federally funded by Brazil, said it had begun distributing the vaccine after doses arrived from India on Friday.
Although the Brazilian government currently has an agreement with AstraZeneca to produce up to 100 million doses of its vaccine locally, the country has recently faced delays from China in delivering the active ingredient needed to produce it. the.
AstraZeneca agreed to give Brazil 2 million ready-to-use doses in India for the government to start distributing the vaccine to its citizens, Reuters reported.
The distribution comes when Brazil has so far relied on the Chinese Sinovac vaccine, which Brazilian health officials said last week just over 50 percent effective when it comes to preventing COVID-19, an efficiency rate much lower than that of 78% of civil servants São Paulo was calculated above.
However, that of São Paulo The Butantan Institute argues that Chinese inoculation remains 100% effective in preventing “severe” or “moderate” coronavirus infections, while mild or very mild infections remain possible after receiving the vaccine.
Brazil has the second highest number of deaths from COVID-19 in the world, with more than 216,000 as of Saturday, according to data collected by Johns Hopkins University. The South American country also ranks third for total infections, with more than 8.8 million people reported.
The UK earlier this month became the first country to begin administering the AstraZeneca vaccine, which was developed through a partnership with Oxford University. India and Pakistan have also approved inoculation for use.
Trial data revealed that the AstraZeneca vaccine had an efficacy rate of 62% if administered in full doses 28 days apart, as was the case for most participants. However, the vaccine was found to be 90% effective when administered by mistake to a small group of the half-dose trial initially followed by a full dose.
Faced with questions about trial data, U.S. health experts initially predicted that it would take months to receive emergency approval for the AstraZeneca vaccine, although Anthony Fauci
Anthony Fauci: Distribution of AstraZeneca vaccine begins in Brazil Biden and British Prime Minister discuss NATO and multilateralism during Sunday’s call: all eyes on the Biden administration to fight coronavirus MORE, the country’s top infectious disease expert, said last week that approval of the shot, as well as one from Johnson & Johnson, was there are likely to be “weeks away.”